San Diego, CA, United States of America

Andrew P Mazar

USPTO Granted Patents = 14 

 


Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 79(Granted Patents)


Location History:

  • La Jolla, CA (US) (1999 - 2005)
  • Escondido, CA (US) (2004 - 2012)
  • San Diego, CA (US) (2005 - 2012)

Company Filing History:


Years Active: 1999-2012

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Andrew P. Mazar: Innovator in Cancer Treatment

Introduction

Andrew P. Mazar, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of biomedical research through his innovative patents. With a portfolio of 14 patents, Mazar has focused primarily on developing therapeutic agents aimed at combating cancer.

Latest Patents

Among his latest patents is a breakthrough in anti-invasive and anti-angiogenic compositions. This invention features a peptide compound characterized by the sequence Lys-Pro-Ser-Ser-Pro-Pro-Glu-Glu [SEQ ID NO:2] or its variants. This compound is designed to inhibit cell invasion, endothelial tube formation, and angiogenesis in vitro, presenting a promising method for treating diseases associated with uncontrolled cell growth and metastasis, particularly tumors.

Another significant patent by Mazar pertains to monoclonal antibodies specific to the urokinase-type plasminogen activator receptor (uPAR). These antibodies target a specific epitope on uPAR, obstructing its signaling pathways. This application has critical implications for diagnostic and therapeutic methods against cancer, marking a considerable advancement in targeted cancer treatment strategies.

Career Highlights

Andrew P. Mazar has established a robust career in pharmaceutical development. He has worked with notable companies, including Angstrom Pharmaceuticals, Inc. and Attenuon, LLC, where he contributed to cutting-edge research and the development of cancer treatment solutions.

Collaborations

Throughout his career, Mazar has collaborated with esteemed professionals in the field, including Terence R. Jones and Graham Parry. These partnerships have enriched his research endeavors and have played a key role in his innovative projects.

Conclusion

Andrew P. Mazar’s work exemplifies the vital intersection of science and innovation in the fight against cancer. His numerous patents underscore his commitment to advancing medical treatments and improving patient outcomes, making him a leading figure in his field. As research and development continue to evolve, Mazar’s contributions are likely to leave a lasting impact on cancer therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…